Scotiabank Sticks to Their Buy Rating for EyePoint Pharmaceuticals (EYPT)
In a report released today, Greg Harrison from Scotiabank maintained a Buy rating on EyePoint Pharmaceuticals (EYPT – Research Report), with a ...